Researchers in China injected genetically spliced cells into a human patient for the first time last month hoping that they may see a breakthrough treating an aggressive form of lung cancer. The cells were altered using so-called CRISPR-Cas9 “scissors,” which let scientists target specific problem genes in a DNA strand and remove them from the genome.
